Pain during dry needling of an active Myofascial trigger Point in the Upper Trapezius Muscle Pain during dry needling, pain from dry needling, pain associated with dry needling
Conditions
Interventions
Sixty minutes before dry needling, the participant was administered 1 g of topical lidocaine-prilocaine cream over the dry needling site. Specifically, the researcher marked the dry needling site ove
Experimental Drug,Placebo Comparator Drug
EMLA Cream (lidocaine 2.5% and prilocaine 2.5%),Siriraj Daily Cream
Sponsors
Phramongkutklao Hospital Foundation
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Presented at least 1 active Myofascial trigger point in the upper trapezius, 2. Volunteers completing inform consent for their participation and dry needling procedure
Exclusion criteria
Exclusion criteria: 1. Contraindication for dry needling included needle phobia, coagulopathy, thrombocytopenia, and psychiatric disorder, 2. History of analgesic or NSAIDs use in 24 hours, 3. Altered mental status or inability to comprehend question, 4. Contraindication for EMLA (lidocaine/prilocaine), 5. Pregnant women or breastfeeder, 6. denuded or broken skin over myofascial trigger point site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain during dry needling Immediately after 10 insertions of dry needling 100-mm visual analogue scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain while needle penetrating through skin Immediately after the needle penetrating through skin 100-mm visual analogue scale | — |
Countries
Thailand
Contacts
Public ContactPimpika Fuktongphan
Phramongkutklao Hospital
Outcome results
None listed